Screening for iron deficiency and iron deficiency anaemia in pregnancy: a structured review and gap analysis against UK national screening criteria

BMC Pregnancy and Childbirth

Simon J Stanworth¹  David Roberts¹  Michael F Murphy¹  Marian Knight²  Ruramayi Rukuni² 

[1] Department of Haematology, John Radcliffe Hospital, NHS Blood & Transplant/Oxford University Hospital Trust, University of Oxford, Oxford, UK;National Perinatal Epidemiology Unit, University of Oxford, Old Road, Campus, Oxford OX3 7LF, UK

关键词: screening;    pregnancy;    iron deficiency;    iron;    Anaemia;   

Others  :  1229140
DOI  :  10.1186/s12884-015-0679-9

 received in 2015-03-19, accepted in 2015-10-04,  发布年份 2015

【 摘 要 】

Background

Iron deficiency anaemia is a common problem in pregnancy despite national recommendations and guidelines for treatment. The aim of this study was to appraise the evidence against the UK National Screening Committee (UKNSC) criteria as to whether a national screening programme could reduce the prevalence of iron deficiency anaemia and/or iron deficiency in pregnancy and improve maternal and fetal outcomes.

Methods

Search strategies were developed for the Cochrane library, Medline and Embase to identify evidence relevant to UK National Screening Committee (UKNSC) appraisal criteria which cover the natural history of iron deficiency and iron deficiency anaemia, the tests for screening, clinical management and evidence of cost effectiveness.

Results

Many studies evaluated haematological outcomes of anaemia, but few analysed clinical consequences. Haemoglobin and ferritin appeared the most suitable screening tests, although future options may follow recent advances in understanding iron homeostasis. The clinical consequences of iron deficiency without anaemia are unknown. Oral and intravenous iron are effective in improving haemoglobin and iron parameters. There have been no trials or economic evaluations of a national screening programme for iron deficiency anaemia in pregnancy.

Conclusions

Iron deficiency in pregnancy remains an important problem although effective tests and treatment exist. A national screening programme could be of value for early detection and intervention. However, high quality studies are required to confirm whether this would reduce maternal and infant morbidity and be cost effective.

【 授权许可】

   
2015 Rukuni et al.

【 参考文献 】

• [1]Stevens G, Finucane M, De-Regil L, Paciorek C, Flaxman S, Branca F, et al. Global, regional, and national trends in haemoglobin concentration and prevalence of total and severe anaemia in children and pregnant and non-pregnant women for 1995–2011: a systematic analysis of population-representative data. Lancet Global Health. 2013;1:e16–25.
• [2]Barroso F, Allard S, Kahan BC, Connolly C, Smethurst H, Choo L, et al. Prevalence of maternal anaemia and its predictors: a multi-centre study. Eur J Obstet Gynecol Reprod Biol. 2011;159(1):99–105.
• [3]Milman N. Prepartum anaemia: prevention and treatment. Ann Hematol. 2008; 87(12):949-959.
• [4]National Institute for Health and Care Excellence (NICE). Clinical Guideline 62, Antenatal Care: routine care for the healthy pregnant woman.National Collaborating Centre for Women's and Children's Health (UK). London: RCOG Press. 2008. ISBN-13: 978-1-904752-46-2.
• [5]Pavord S, Myers B, Robinson S, Allard S, Strong J, Oppenheimer C, et al. UK guidelines on the management of iron deficiency in pregnancy. Br J Haematol. 2012;156(5):588–600.
• [6]Royal College of Obstericians and Gynaecologists. RCOG: Blood Transfusions in Obstetrics Green-top 47. 2007. Available online from:. https://www. rcog.org.uk/globalassets/documents/guidelines/gt47bloodtransfusions1207amended.pdf webcite
• [7]World Health Organisations. WHO: Iron deficiency anaemia assessment prevention and control. A guide for programme managers. WHO/NHD/013. 2001. Available online from:. http://www. who.int/nutrition/publications/en/ida_assessment_prevention_control.pdf webcite
• [8]Centre for Disease Control and Prevention: Recommendations to prevent and control iron deficiency in the United States. MMWR Recomm Rep. 1998; 47:1-29.
• [9]Oregon Evidence-Based Practice Center. Screening for Iron Deficiency Anemia in Childhood and Pregnancy: Update of the 1996 U.S. Preventive Services Task Force Review. AHRQ Publication No. 06- 0590-EF-1. Evidence Synthesis No. 40. Rockville, MD: Agency for Healthcare Research and Quality; 2006.
• [10]RANZCOG: College Statement: Pre-pregnancy Counselling and Routine Antenatal Assessment in the Absence of Pregnancy Complications (C-Obs-3) In. Edited by Gynaecologists TRAaNZCoOa. Melbourne, Australia: The Royal Australian and New Zealand College of Obstetricians and Gynaecologists; 2009
• [11]Pasricha S-R. Should we screen for iron deficiency anaemia? A review of the evidence and recent recommendations. Pathology. 2012; 44(2):139-147.
• [12]Milman N. Postpartum anemia II: prevention and treatment. Ann Hematol. 2012; 91(2):143-154.
• [13]Programme Appraisal Criteria. http://www. screening.nhs.uk/criteria webcite
• [14]World Health Organisation. Worldwide prevalence of anaemia 1993–2005: WHO global database on anaemia. Edited by Bruno de Benoist, Erin McLean, Ines Egli and Mary Cogswell. 2008 Available online from:. http://apps. who.int/iris/bitstream/10665/43894/1/9789241596657_eng.pdf webcite
• [15]WHO: Prevalence of Anaemia in Women: A Tabulation of Available Information. In. Edited by Organisation WH, vol. WHO/MCH/MSM/92.2. Geneva: World Health Organisation; 1992
• [16]McClung JP, Murray-Kolb LE. Iron nutrition and premenopausal women: effects of poor iron status on physical and neuropsychological performance. Annu Rev Nutr. 2013; 33:271-288.
• [17]Bencaiova G, Breymann C. Mild Anemia and Pregnancy Outcome in a Swiss Collective. J Pregnancy. 2014; 2014:7.
• [18]Ferguson SA: Why ferritin measurement at 28 weeks of gestation is advisable. BJOG: An International Journal of Obstetrics and Gynaecology 2013, Conference: RCOG World Congress 2013 Liverpool United Kingdom. Conference Start: 20130624 Conference End: 20130626. Conference Publication: (var.pagings). 120:164.
• [19]Vaucher P, Druais PL, Waldvogel S, Favrat B: Effect of iron supplementation on fatigue in nonanemic menstruating women with low ferritin: a randomized controlled trial. CMAJ 012, 184(11):1247–1254
• [20]Lozoff B, Beard J, Connor J, Felt B, Georgieff M, Schallert T. Long-lasting neural and behavioral effects of iron deficiency in infancy. Nutrition Reviews. 2006; 64((5 SUPPL. 1)):S34-S43.
• [21]Erdem A, Erdem M, Arslan M, Yazici G, Eskandari R, Himmetoglu O. The effect of maternal anemia and iron deficiency on fetal erythropoiesis: comparison between serum erythropoietin, hemoglobin and ferritin levels in mothers and newborns. J Matern Fetal Neonatal Med. 2002; 11(5):329-332.
• [22]McCann JC, Ames BN. An overview of evidence for a causal relation between iron deficiency during development and deficits in cognitive or behavioral function. Am J Clin Nutr. 2007; 85(4):931-945.
• [23]HSE: Health Survey for England: Health of Minority Ethnic Groups Summary of Findings. In. Edited by Centre HaSCI; 2006.
• [24]Streetly A, Latinovic R, Henthorn J. Positive screening and carrier results for the England- wide universal newborn sickle cell screening programme by ethnicity and area for 2005–07. J Clin Pathol. 2010; 63(7):626-629.
• [25]SACN: Iron and Health. In. London: The Scientific Advisory Committee on Nutrition; 2010
• [26]Scholl TO. Iron status during pregnancy: setting the stage for mother and infant. Am J Clin Nutr. 2005; 81(5):1218S-1222S.
• [27]Kleinman S, King MR, Busch MP, Murphy EL, Glynn SA. The National Heart, Lung, and Blood Institute retrovirus epidemiology donor studies (Retrovirus Epidemiology Donor Study and Retrovirus Epidemiology Donor Study-II): twenty years of research to advance blood product safety and availability. Transfus Med Rev. 2012; 26(4):281-304.
• [28]Gera T, Sachdev HS, Boy E. Effect of iron-fortified foods on hematologic and biological outcomes: systematic review of randomized controlled trials. American Am J Clin Nutr. 2012; 96(2):309-324.
• [29]UK Government. Bread and Flour Regulations. Statutory Instrument No 141. London 1998. Available online from:. http://www. legislation.gov.uk/uksi/1998/141/made webcite
• [30]Girard AW, Olude O. Nutrition education and counselling provided during pregnancy: effects on maternal, neonatal and child health outcomes. [Review]. Paediatr Perinat Epidemiol. 2012; 26 Suppl 1:191-204.
• [31]WHO/CDC: Assessing the iron status of populations:including literature reviews: report of a Joint WHO/CDC Technical Consultation on the Assessment of Iron Status at the Population Level. In. Geveva: World Health Organisation/ Centers for Disease Control and Prevention; 2007.
• [32]Bresani CC, Braga MC, Felisberto DF, Tavares-de-Melo CEL, Salvi DB, Batista-Filho M: Accuracy of erythrogram and serum ferritin for the maternal anemia diagnosis (AMA): A phase 3 diagnostic study on prediction of the therapeutic responsiveness to oral iron in pregnancy. BMC Pregnancy Childbirth. 2013;13(13).
• [33]Kroot JJC, Tjalsma H, Fleming RE, Swinkels DW. Hepcidin in Human Iron Disorders: Diagnostic Implications. Clin Chem. 2011; 57(12):1650-1669.
• [34]Van Santen S, Kroot JJC, Zijderveld G, Wiegerinck ET, Spaanderman MEA, Swinkels DW. The iron regulatory hormone hepcidin is decreased in pregnancy: A prospective longitudinal study. Clin Chem Lab Med. 2013; 51(7):1395-1401.
• [35]WHO: Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. In., vol. WHO/NMH/NHD/MNM/11.1. Geneva: World Health Organisation; 2011.
• [36]CDC: Recommendations to prevent and control iron deficiency in the United States. Centers for Disease Control and Prevention. MMWR Recomm Rep 1998, Recommendations & Reports. 47(RR-3):1–29.
• [37]Hallberg L, Bengtsson C, Lapidus L, Lindstedt G, Lundberg P-A, Hultén L. Screening for iron deficiency: an analysis based on bone-marrow examinations and serum ferritin determinations in a population sample of women. Br J Haematol. 1993; 85(4):787-798.
• [38]van den Broek N. Anaemia in pregnancy in developing countries. Br J Obstet Gynaecol. 1998; 105(4):385-390.
• [39]Dormandy E, Bryan S, Gulliford M, Roberts T, Ades A, Calnan M, Atkin K, Karnon J, Barton P, Logan J et al.: Antenatal screening for haemoglobinopathies in primary care: a cohort study and cluster randomised trial to inform a simulation model. The Screening for Haemoglobinopathies in First Trimester (SHIFT) trial. Health Technology Assessment 2010, 14(20).
• [40]Parker JA, F. B, J. SS, H. S, S. H, J. DC, J. RM, Allard S: Gaps in the evidence for prevention and treatment of maternal anaemia: a review of systematic reviews. BMC Pregnancy Childbirth. 2012;12:56.
• [41]Haider BA, Olofin I, Wang M, Spiegelman D, Ezzati M, Fawzi WW, et al. Anaemia, prenatal iron use, and risk of adverse pregnancy outcomes: Systematic review and meta-analysis. BMJ (Online). 2013;347(7916):f3443.
• [42]De-Regil Luz M, Jefferds Maria Elena D, Sylvetsky Allison C, Dowswell T: Intermittent iron supplementation for improving nutrition and development in children under 12 years of age. In: Cochrane Database of Systematic Reviews. John Wiley & Sons, Ltd; 2011
• [43]Reveiz L, Gyte GM, Cuervo LG, Casasbuenas A: Treatments for iron-deficiency anaemia in pregnancy. [Review] [Update of Cochrane Database Syst Rev. 2007;(2):CD003094; PMID: 17443522]. Cochrane Database Syst Rev. 2011;(10):CD003094.
• [44]Garn SM, Ridella SA, Petzold AS, Falkner F. Maternal Hematologic Levels and Pregnancy Outcomes. Sem in Perinatol. 1981; 5:115-162.
• [45]Murphy JF, Newcombe RG, O'Riordan J, Coles EC, Pearson JF. Relation of haemoglobin levels in first and second trimesters to outcome of pregnancy. The Lancet. 1986; 327(8488):992-995.
• [46]Little MP, Brocard P, Elliott P, Steer PJ. Hemoglobin concentration in pregnancy and perinatal mortality: A London-based cohort study. Am J Obstet Gynecol. 2005; 193(1):220-226.
• [47]Balarajan Y, Ramakrishnan U, Özaltin E, Shankar AH, Subramanian SV. Anaemia in low-income and middle-income countries. The Lancet. 2011; 378(9809):2123-2135.
• [48]James JA, Laing GJ, Logan S, Rossdale M. Feasibility of screening toddlers for iron deficiency anaemia in general practice. BMJ. 1997; 315:102-103.
• [49]Moy RJ, Aukett A. Screening toddlers for iron deficiency anaemia in general practice. Screening is possible in populations similar to one studied by authors. BMJ. 1998; 316:145.
• [50]Britto MT. Using evidence-based techniques to modify anemia screening practice. Am J Manag Care. 1997; 3:1507-1509.
• [51]UKNSC: NHS sicke cell and thalassaemia screening programme: standards for the linked antenatal and newborn screening programme. In. Online; 2011
• [52]Litton E, Xiao J, Ho KM: Safety and efficacy of intravenous iron therapy in reducing requirement for allogeneic blood transfusion: systematic review and meta-analysis of randomised clinical trials. Kwok-ming. In: British Medical Journal, Vol. 347, No. 7923, 2013, p. doi:10.1136/bmj.f4822.
• [53]BNF: British National Formulary (BNF) 68: BMJ Publishing Group Ltd and Royal Pharmaceutical Society; 2014.
• [54]Medicines Compendium. https://http://www. medicines.org.uk/emc/ webcite